Global Immune Checkpoint Inhibitors Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-16374875 | Publishing Date : 08-Sep-2020 | No. of pages : 130
Detailed TOC of Global Immune Checkpoint Inhibitors Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Immune Checkpoint Inhibitors Market Overview1.1 Immune Checkpoint Inhibitors Product Overview
1.2 Immune Checkpoint Inhibitors Market Segment by Type
1.2.1 PD-1/PD-L1
1.2.2 CTLA-4
1.3 Global Immune Checkpoint Inhibitors Market Size by Type (2015-2026)
1.3.1 Global Immune Checkpoint Inhibitors Market Size Overview by Type (2015-2026)
1.3.2 Global Immune Checkpoint Inhibitors Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Immune Checkpoint Inhibitors Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global Immune Checkpoint Inhibitors Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Immune Checkpoint Inhibitors Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Global Immune Checkpoint Inhibitors Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Immune Checkpoint Inhibitors Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Immune Checkpoint Inhibitors Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Immune Checkpoint Inhibitors Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America Immune Checkpoint Inhibitors Sales Breakdown by Type (2015-2026)
1.4.2 Europe Immune Checkpoint Inhibitors Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Immune Checkpoint Inhibitors Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Immune Checkpoint Inhibitors Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Immune Checkpoint Inhibitors Sales Breakdown by Type (2015-2026)
2 Global Immune Checkpoint Inhibitors Market Competition by Company
2.1 Global Top Players by Immune Checkpoint Inhibitors Sales (2015-2020)
2.2 Global Top Players by Immune Checkpoint Inhibitors Revenue (2015-2020)
2.3 Global Top Players Immune Checkpoint Inhibitors Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers Immune Checkpoint Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immune Checkpoint Inhibitors Market Competitive Situation and Trends
2.5.1 Immune Checkpoint Inhibitors Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by Immune Checkpoint Inhibitors Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Checkpoint Inhibitors as of 2019)
2.7 Date of Key Manufacturers Enter into Immune Checkpoint Inhibitors Market
2.8 Key Manufacturers Immune Checkpoint Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Global Immune Checkpoint Inhibitors Status and Outlook by Region (2015-2026)
3.1 Global Immune Checkpoint Inhibitors Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global Immune Checkpoint Inhibitors Market Size Market Share by Region (2015-2020)
3.2.1 Global Immune Checkpoint Inhibitors Sales Market Share by Region (2015-2020)
3.2.2 Global Immune Checkpoint Inhibitors Revenue Market Share by Region (2015-2020)
3.2.3 Global Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global Immune Checkpoint Inhibitors Market Size Market Share by Region (2021-2026)
3.3.1 Global Immune Checkpoint Inhibitors Sales Market Share by Region (2021-2026)
3.3.2 Global Immune Checkpoint Inhibitors Revenue Market Share by Region (2021-2026)
3.3.3 Global Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
3.4.1 North America Immune Checkpoint Inhibitors Revenue YoY Growth (2015-2026)
3.4.2 North America Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026)
3.5 Asia-Pacific Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
3.5.1 Asia-Pacific Immune Checkpoint Inhibitors Revenue YoY Growth (2015-2026)
3.5.2 Asia-Pacific Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026)
3.6 Europe Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
3.6.1 Europe Immune Checkpoint Inhibitors Revenue YoY Growth (2015-2026)
3.6.2 Europe Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026)
3.7 Latin America Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
3.7.1 Latin America Immune Checkpoint Inhibitors Revenue YoY Growth (2015-2026)
3.7.2 Latin America Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026)
3.8 Middle East and Africa Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
3.8.1 Middle East and Africa Immune Checkpoint Inhibitors Revenue YoY Growth (2015-2026)
3.8.2 Middle East and Africa Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026)
4 Global Immune Checkpoint Inhibitors by Application
4.1 Immune Checkpoint Inhibitors Segment by Application
4.1.1 Lung Cancer
4.1.2 Colorectal Cancer
4.1.3 Breast Cancer
4.1.4 Prostate Cancer
4.1.5 Melanoma
4.1.6 Blood Cancer
4.1.7 Other
4.2 Global Immune Checkpoint Inhibitors Sales by Application: 2015 VS 2020 VS 2026
4.3 Global Immune Checkpoint Inhibitors Historic Sales by Application (2015-2020)
4.4 Global Immune Checkpoint Inhibitors Forecasted Sales by Application (2021-2026)
4.5 Key Regions Immune Checkpoint Inhibitors Market Size by Application
4.5.1 North America Immune Checkpoint Inhibitors by Application
4.5.2 Europe Immune Checkpoint Inhibitors by Application
4.5.3 Asia-Pacific Immune Checkpoint Inhibitors by Application
4.5.4 Latin America Immune Checkpoint Inhibitors by Application
4.5.5 Middle East and Africa Immune Checkpoint Inhibitors by Application
5 North America Immune Checkpoint Inhibitors Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
5.1.2 North America Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Immune Checkpoint Inhibitors Sales Market Share by Country (2021-2026)
5.2.2 North America Immune Checkpoint Inhibitors Revenue Market Share by Country (2021-2026)
5.3 North America Market Size YoY Growth by Country
5.3.1 U.S. Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
5.3.2 Canada Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
6 Europe Immune Checkpoint Inhibitors Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
6.1.2 Europe Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe Immune Checkpoint Inhibitors Sales Market Share by Country (2021-2026)
6.2.2 Europe Immune Checkpoint Inhibitors Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size YoY Growth by Country
6.3.1 Germany Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
6.3.2 France Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
6.3.3 U.K. Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
6.3.4 Italy Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
6.3.5 Russia Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7 Asia-Pacific Immune Checkpoint Inhibitors Market Size by Country (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)
7.1.1 Asia-Pacific Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
7.1.2 Asia-Pacific Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)
7.2.1 Asia-Pacific Immune Checkpoint Inhibitors Sales Market Share by Country (2021-2026)
7.2.2 Asia-Pacific Immune Checkpoint Inhibitors Revenue Market Share by Country (2021-2026)
7.3 Asia-Pacific Market Size YoY Growth by Country
7.3.1 China Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.2 Japan Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.3 South Korea Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.4 India Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.5 Australia Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.6 Taiwan Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.7 Indonesia Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.8 Thailand Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.9 Malaysia Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.10 Philippines Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
7.3.11 Vietnam Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
8 Latin America Immune Checkpoint Inhibitors Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
8.1.2 Latin America Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America Immune Checkpoint Inhibitors Sales Market Share by Country (2021-2026)
8.2.2 Latin America Immune Checkpoint Inhibitors Revenue Market Share by Country (2021-2026)
8.3 Latin America Market Size YoY Growth by Country
8.3.1 Mexico Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
8.3.2 Brazil Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
8.3.3 Argentina Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
9 Middle East and Africa Immune Checkpoint Inhibitors Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa Immune Checkpoint Inhibitors Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa Immune Checkpoint Inhibitors Revenue Market Share by Country (2021-2026)
9.3 Middle East and Africa Market Size YoY Growth by Country
9.3.1 Turkey Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
9.3.2 Saudi Arabia Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
9.3.3 U.A.E Immune Checkpoint Inhibitors Market Size YoY Growth (2015-2026)
10 Company Profiles and Key Figures in Immune Checkpoint Inhibitors Business
10.1 Bristol Myer Squibb
10.1.1 Bristol Myer Squibb Corporation Information
10.1.2 Bristol Myer Squibb Description, Business Overview and Total Revenue
10.1.3 Bristol Myer Squibb Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.1.4 Bristol Myer Squibb Immune Checkpoint Inhibitors Products Offered
10.1.5 Bristol Myer Squibb Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Corporation Information
10.2.2 AstraZeneca Description, Business Overview and Total Revenue
10.2.3 AstraZeneca Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.2.4 Bristol Myer Squibb Immune Checkpoint Inhibitors Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Merck & Co.
10.3.1 Merck & Co. Corporation Information
10.3.2 Merck & Co. Description, Business Overview and Total Revenue
10.3.3 Merck & Co. Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.3.4 Merck & Co. Immune Checkpoint Inhibitors Products Offered
10.3.5 Merck & Co. Recent Development
10.4 Roche / Genentech
10.4.1 Roche / Genentech Corporation Information
10.4.2 Roche / Genentech Description, Business Overview and Total Revenue
10.4.3 Roche / Genentech Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.4.4 Roche / Genentech Immune Checkpoint Inhibitors Products Offered
10.4.5 Roche / Genentech Recent Development
10.5 Incyte Corporation
10.5.1 Incyte Corporation Corporation Information
10.5.2 Incyte Corporation Description, Business Overview and Total Revenue
10.5.3 Incyte Corporation Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.5.4 Incyte Corporation Immune Checkpoint Inhibitors Products Offered
10.5.5 Incyte Corporation Recent Development
10.6 NewLink Genetics
10.6.1 NewLink Genetics Corporation Information
10.6.2 NewLink Genetics Description, Business Overview and Total Revenue
10.6.3 NewLink Genetics Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.6.4 NewLink Genetics Immune Checkpoint Inhibitors Products Offered
10.6.5 NewLink Genetics Recent Development
10.7 ArGEN-X
10.7.1 ArGEN-X Corporation Information
10.7.2 ArGEN-X Description, Business Overview and Total Revenue
10.7.3 ArGEN-X Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.7.4 ArGEN-X Immune Checkpoint Inhibitors Products Offered
10.7.5 ArGEN-X Recent Development
10.8 Seattle Genetics
10.8.1 Seattle Genetics Corporation Information
10.8.2 Seattle Genetics Description, Business Overview and Total Revenue
10.8.3 Seattle Genetics Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.8.4 Seattle Genetics Immune Checkpoint Inhibitors Products Offered
10.8.5 Seattle Genetics Recent Development
10.9 Pfizer
10.9.1 Pfizer Corporation Information
10.9.2 Pfizer Description, Business Overview and Total Revenue
10.9.3 Pfizer Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.9.4 Pfizer Immune Checkpoint Inhibitors Products Offered
10.9.5 Pfizer Recent Development
10.10 MacroGenics
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
10.10.3 MacroGenics Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
10.10.4 Main Business Overview
10.10.5 MacroGenics Recent Development
10.11 Celldex Therapeutics
10.11.1 Celldex Therapeutics Corporation Information
10.11.2 Celldex Therapeutics Description, Business Overview and Total Revenue
10.11.3 Celldex Therapeutics Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.11.4 Celldex Therapeutics Immune Checkpoint Inhibitors Products Offered
10.11.5 Celldex Therapeutics Recent Development
10.12 CureTech
10.12.1 CureTech Corporation Information
10.12.2 CureTech Description, Business Overview and Total Revenue
10.12.3 CureTech Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.12.4 CureTech Immune Checkpoint Inhibitors Products Offered
10.12.5 CureTech Recent Development
10.13 Immutep
10.13.1 Immutep Corporation Information
10.13.2 Immutep Description, Business Overview and Total Revenue
10.13.3 Immutep Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.13.4 Immutep Immune Checkpoint Inhibitors Products Offered
10.13.5 Immutep Recent Development
10.14 Innate Pharma
10.14.1 Innate Pharma Corporation Information
10.14.2 Innate Pharma Description, Business Overview and Total Revenue
10.14.3 Innate Pharma Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.14.4 Innate Pharma Immune Checkpoint Inhibitors Products Offered
10.14.5 Innate Pharma Recent Development
10.15 Sorrento Therapeutics
10.15.1 Sorrento Therapeutics Corporation Information
10.15.2 Sorrento Therapeutics Description, Business Overview and Total Revenue
10.15.3 Sorrento Therapeutics Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.15.4 Sorrento Therapeutics Immune Checkpoint Inhibitors Products Offered
10.15.5 Sorrento Therapeutics Recent Development
10.16 GlaxoSmithKline
10.16.1 GlaxoSmithKline Corporation Information
10.16.2 GlaxoSmithKline Description, Business Overview and Total Revenue
10.16.3 GlaxoSmithKline Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.16.4 GlaxoSmithKline Immune Checkpoint Inhibitors Products Offered
10.16.5 GlaxoSmithKline Recent Development
10.17 GITR, Inc
10.17.1 GITR, Inc Corporation Information
10.17.2 GITR, Inc Description, Business Overview and Total Revenue
10.17.3 GITR, Inc Immune Checkpoint Inhibitors Sales, Revenue and Gross Margin (2015-2020)
10.17.4 GITR, Inc Immune Checkpoint Inhibitors Products Offered
10.17.5 GITR, Inc Recent Development
11 Immune Checkpoint Inhibitors Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immune Checkpoint Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immune Checkpoint Inhibitors Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Porter’s Five Forces Analysis
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer
List of Figures, Tables and Charts Available in Global Immune Checkpoint Inhibitors Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Players of PD-1/PD-L1
Table 2. Major Players of CTLA-4
Table 3. Global Immune Checkpoint Inhibitors Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million)
Table 4. Global Immune Checkpoint Inhibitors Sales (MT) by Type (2015-2020) (MT)
Table 5. Global Immune Checkpoint Inhibitors Sales Share by Type (2015-2020)
Table 6. Global Immune Checkpoint Inhibitors Revenue (Million USD) by Type (2015-2020)
Table 7. Global Immune Checkpoint Inhibitors Revenue Share by Type (2015-2020)
Table 8. Global Immune Checkpoint Inhibitors Average Selling Price (ASP) (USD/Kg) by Type (2015-2020)
Table 9. Global Immune Checkpoint Inhibitors Sales by Type (2021-2026) (MT)
Table 10. Global Immune Checkpoint Inhibitors Sales Share by Type (2021-2026)
Table 11. Global Immune Checkpoint Inhibitors Revenue (US$ Million) by Type (2021-2026)
Table 12. Global Immune Checkpoint Inhibitors Revenue Share by Type (2021-2026)
Table 13. Global Immune Checkpoint Inhibitors Average Selling Price (ASP) (USD/Kg) by Type (2021-2026)
Table 14. North America Immune Checkpoint Inhibitors Sales (USD/Kg) by Type (2015-2020)
Table 15. Europe Immune Checkpoint Inhibitors Sales (USD/Kg) by Type (2015-2020)
Table 16. Asia-Pacific Immune Checkpoint Inhibitors Sales (USD/Kg) by Type (2015-2020)
Table 17. Latin America Immune Checkpoint Inhibitors Sales (USD/Kg) by Type (2015-2020)
Table 18. Middle East and Africa Immune Checkpoint Inhibitors Sales (USD/Kg) by Type (2015-2020)
Table 19. Global Immune Checkpoint Inhibitors Sales (MT) by Company (2015-2020)
Table 20. Global Immune Checkpoint Inhibitors Sales Share by Company (2015-2020)
Table 21. Global Immune Checkpoint Inhibitors Revenue (Million US$) by Company (2015-2020)
Table 22. Global Immune Checkpoint Inhibitors Revenue Share by Company (2015-2020)
Table 23. Global Market Immune Checkpoint Inhibitors Average Selling Price (USD/Kg) by Company (2015-2020)
Table 24. Global Immune Checkpoint Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 25. Global Immune Checkpoint Inhibitors Top Manufacturers Product Category
Table 26. Global Immune Checkpoint Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Checkpoint Inhibitors as of 2019
Table 28. Date of Key Manufacturers Enter into Immune Checkpoint Inhibitors Market
Table 29. Key Manufacturers Immune Checkpoint Inhibitors Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Immune Checkpoint Inhibitors Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026
Table 32. Global Immune Checkpoint Inhibitors Sales (MT) by Region (2015-2020)
Table 33. Global Immune Checkpoint Inhibitors Sales Market Share by Region (2015-2020)
Table 34. Global Immune Checkpoint Inhibitors Revenue (US$ Million) by Region (2015-2020)
Table 35. Global Immune Checkpoint Inhibitors Revenue Market Share by Region (2015-2020)
Table 36. Global Immune Checkpoint Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 37. Global Immune Checkpoint Inhibitors Sales (MT) by Region (2021-2026)
Table 38. Global Immune Checkpoint Inhibitors Sales Market Share by Region (2021-2026)
Table 39. Global Immune Checkpoint Inhibitors Revenue (US$ Million) by Region (2021-2026)
Table 40. Global Immune Checkpoint Inhibitors Revenue Market Share by Region (2021-2026)
Table 41. Global Immune Checkpoint Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 42. Global Immune Checkpoint Inhibitors Sales (MT) by Application: 2015 VS 2020 VS 2026
Table 43. Global Immune Checkpoint Inhibitors Sales (MT) by Application (2015-2020)
Table 44. Global Immune Checkpoint Inhibitors Sales Share by Application (2015-2020)
Table 45. Global Immune Checkpoint Inhibitors Sales (MT) by Application (2021-2026)
Table 46. Global Immune Checkpoint Inhibitors Sales Share by Application (2021-2026)
Table 47. North America Immune Checkpoint Inhibitors Sales (MT) by Application (2015-2020)
Table 48. North America Sales Immune Checkpoint Inhibitors Market Share by Application (2015-2020)
Table 49. Europe Immune Checkpoint Inhibitors Sales (MT) by Application (2015-2020)
Table 50. Europe Sales Immune Checkpoint Inhibitors Market Share by Application In 2019
Table 51. Asia-Pacific Immune Checkpoint Inhibitors Sales (MT) by Application (2015-2020)
Table 52. Asia-Pacific Sales Immune Checkpoint Inhibitors Market Share by Application In 2019
Table 53. Latin America Immune Checkpoint Inhibitors Sales (MT) by Application (2015-2020)
Table 54. Latin America Sales Immune Checkpoint Inhibitors Market Share by Application In 2019
Table 55. Middle East and Africa Immune Checkpoint Inhibitors Sales (MT) by Application (2015-2020)
Table 56. Middle East and Africa Immune Checkpoint Inhibitors Sales Share by Application (2015-2020)
Table 57. North America Immune Checkpoint Inhibitors Sales (MT) by Country (2015-2020)
Table 58. North America Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
Table 59. North America Immune Checkpoint Inhibitors Revenue (US$ Million) by Country (2015-2020)
Table 60. North America Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
Table 61. North America Immune Checkpoint Inhibitors Sales (MT) by Country (2021-2026)
Table 62. North America Immune Checkpoint Inhibitors Sales Market Share by Country (2021-2026)
Table 63. North America Immune Checkpoint Inhibitors Revenue (US$ Million) by Country (2021-2026)
Table 64. North America Immune Checkpoint Inhibitors Revenue Market Share by Country (2021-2026)
Table 65. Europe Immune Checkpoint Inhibitors Sales (MT) by Country (2015-2020)
Table 66. Europe Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
Table 67. Europe Immune Checkpoint Inhibitors Revenue (US$ Million) by Country (2015-2020)
Table 68. Europe Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
Table 69. Europe Immune Checkpoint Inhibitors Sales (MT) by Country (2021-2026)
Table 70. Europe Immune Checkpoint Inhibitors Sales Market Share by Country (2021-2026)
Table 71. Europe Immune Checkpoint Inhibitors Revenue (US$ Million) by Country (2021-2026)
Table 72. Europe Immune Checkpoint Inhibitors Revenue Market Share by Country (2021-2026)
Table 73. Asia-Pacific Immune Checkpoint Inhibitors Sales (MT) by Region (2015-2020)
Table 74. Asia-Pacific Immune Checkpoint Inhibitors Sales Market Share by Region (2015-2020)
Table 75. Asia-Pacific Immune Checkpoint Inhibitors Revenue (US$ Million) by Region (2015-2020)
Table 76. Asia-Pacific Immune Checkpoint Inhibitors Revenue Market Share by Region (2015-2020)
Table 77. Asia-Pacific Immune Checkpoint Inhibitors Sales (MT) by Region (2021-2026)
Table 78. Asia-Pacific Immune Checkpoint Inhibitors Sales Market Share by Region (2021-2026)
Table 79. Asia-Pacific Immune Checkpoint Inhibitors Revenue (US$ Million) by Region (2021-2026)
Table 80. Asia-Pacific Immune Checkpoint Inhibitors Revenue Market Share by Region (2021-2026)
Table 81. Latin America Immune Checkpoint Inhibitors Sales (MT) by Country (2015-2020)
Table 82. Latin America Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
Table 83. Latin America Immune Checkpoint Inhibitors Revenue (US$ Million) by Country (2015-2020)
Table 84. Latin America Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
Table 85. Latin America Immune Checkpoint Inhibitors Sales (MT) by Country (2021-2026)
Table 86. Latin America Immune Checkpoint Inhibitors Sales Market Share by Country (2021-2026)
Table 87. Latin America Immune Checkpoint Inhibitors Revenue (US$ Million) by Country (2021-2026)
Table 88. Latin America Immune Checkpoint Inhibitors Revenue Market Share by Country (2021-2026)
Table 89. Middle East and Africa Immune Checkpoint Inhibitors Sales (MT) by Country (2015-2020)
Table 90. Middle East and Africa Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
Table 91. Middle East and Africa Immune Checkpoint Inhibitors Revenue (US$ Million) by Country (2015-2020)
Table 92. Middle East and Africa Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
Table 93. Middle East and Africa Immune Checkpoint Inhibitors Sales (MT) by Country (2021-2026)
Table 94. Middle East and Africa Immune Checkpoint Inhibitors Sales Market Share by Country (2021-2026)
Table 95. Middle East and Africa Immune Checkpoint Inhibitors Revenue (US$ Million) by Country (2021-2026)
Table 96. Middle East and Africa Immune Checkpoint Inhibitors Revenue Market Share by Country (2021-2026)
Table 97. Bristol Myer Squibb Corporation Information
Table 98. Bristol Myer Squibb Description and Business Overview
Table 99. Bristol Myer Squibb Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. Bristol Myer Squibb Immune Checkpoint Inhibitors Product
Table 101. Bristol Myer Squibb Recent Development
Table 102. AstraZeneca Corporation Information
Table 103. AstraZeneca Description and Business Overview
Table 104. AstraZeneca Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 105. AstraZeneca Immune Checkpoint Inhibitors Product
Table 106. AstraZeneca Recent Development
Table 107. Merck & Co. Corporation Information
Table 108. Merck & Co. Description and Business Overview
Table 109. Merck & Co. Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 110. Merck & Co. Immune Checkpoint Inhibitors Product
Table 111. Merck & Co. Recent Development
Table 112. Roche / Genentech Corporation Information
Table 113. Roche / Genentech Description and Business Overview
Table 114. Roche / Genentech Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 115. Roche / Genentech Immune Checkpoint Inhibitors Product
Table 116. Roche / Genentech Recent Development
Table 117. Incyte Corporation Corporation Information
Table 118. Incyte Corporation Description and Business Overview
Table 119. Incyte Corporation Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 120. Incyte Corporation Immune Checkpoint Inhibitors Product
Table 121. Incyte Corporation Recent Development
Table 122. NewLink Genetics Corporation Information
Table 123. NewLink Genetics Description and Business Overview
Table 124. NewLink Genetics Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 125. NewLink Genetics Immune Checkpoint Inhibitors Product
Table 126. NewLink Genetics Recent Development
Table 127. ArGEN-X Corporation Information
Table 128. ArGEN-X Description and Business Overview
Table 129. ArGEN-X Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 130. ArGEN-X Immune Checkpoint Inhibitors Product
Table 131. ArGEN-X Recent Development
Table 132. Seattle Genetics Corporation Information
Table 133. Seattle Genetics Description and Business Overview
Table 134. Seattle Genetics Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 135. Seattle Genetics Immune Checkpoint Inhibitors Product
Table 136. Seattle Genetics Recent Development
Table 137. Pfizer Corporation Information
Table 138. Pfizer Description and Business Overview
Table 139. Pfizer Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 140. Pfizer Immune Checkpoint Inhibitors Product
Table 141. Pfizer Recent Development
Table 142. MacroGenics Corporation Information
Table 143. MacroGenics Description and Business Overview
Table 144. MacroGenics Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 145. MacroGenics Immune Checkpoint Inhibitors Product
Table 146. MacroGenics Recent Development
Table 147. Celldex Therapeutics Corporation Information
Table 148. Celldex Therapeutics Description and Business Overview
Table 149. Celldex Therapeutics Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 150. Celldex Therapeutics Immune Checkpoint Inhibitors Product
Table 151. Celldex Therapeutics Recent Development
Table 152. CureTech Corporation Information
Table 153. CureTech Description and Business Overview
Table 154. CureTech Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 155. CureTech Immune Checkpoint Inhibitors Product
Table 156. CureTech Recent Development
Table 157. Immutep Corporation Information
Table 158. Immutep Description and Business Overview
Table 159. Immutep Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 160. Immutep Immune Checkpoint Inhibitors Product
Table 161. Immutep Recent Development
Table 162. Innate Pharma Corporation Information
Table 163. Innate Pharma Description and Business Overview
Table 164. Innate Pharma Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 165. Innate Pharma Immune Checkpoint Inhibitors Product
Table 166. Innate Pharma Recent Development
Table 167. Sorrento Therapeutics Corporation Information
Table 168. Sorrento Therapeutics Description and Business Overview
Table 169. Sorrento Therapeutics Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 170. Sorrento Therapeutics Immune Checkpoint Inhibitors Product
Table 171. Sorrento Therapeutics Recent Development
Table 172. GlaxoSmithKline Corporation Information
Table 173. GlaxoSmithKline Description and Business Overview
Table 174. GlaxoSmithKline Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 175. GlaxoSmithKline Immune Checkpoint Inhibitors Product
Table 176. GlaxoSmithKline Recent Development
Table 177. GITR, Inc Corporation Information
Table 178. GITR, Inc Description and Business Overview
Table 179. GITR, Inc Immune Checkpoint Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 180. GITR, Inc Immune Checkpoint Inhibitors Product
Table 181. GITR, Inc Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 185. Key Challenges
Table 186. Market Risks
Table 187. Distributors List
Table 188. Immune Checkpoint Inhibitors Downstream Customers
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Checkpoint Inhibitors Product Picture
Figure 2. Global Immune Checkpoint Inhibitors Revenue (Million USD) Status and Outlook (2015-2026)
Figure 3. Global Immune Checkpoint Inhibitors Sales (MT) Status and Outlook (2015-2026)
Figure 4. Product Picture of PD-1/PD-L1
Figure 5. Global PD-1/PD-L1 Sales (MT) and Growth Rate (2015-2020)
Figure 6. Product Picture of CTLA-4
Figure 7. Global CTLA-4 Sales (MT) and Growth Rate (2015-2020)
Figure 8. Global Immune Checkpoint Inhibitors Revenue and Growth Rate by Type (US$ Million)
Figure 9. Global Immune Checkpoint Inhibitors Sales Market Share by Type (2015-2020)
Figure 10. Global Immune Checkpoint Inhibitors Sales Market Share by Type in 2019
Figure 11. Global Immune Checkpoint Inhibitors Revenue Share by Type (2015-2020)
Figure 12. Global Immune Checkpoint Inhibitors Revenue Market Share by Type in 2019
Figure 13. Global Immune Checkpoint Inhibitors Sales Market Share by Type (2021-2026)
Figure 14. Global Immune Checkpoint Inhibitors Sales Market Share by Type In 2019
Figure 15. Global Immune Checkpoint Inhibitors Revenue Share by Type (2021-2026)
Figure 16. Global Immune Checkpoint Inhibitors Revenue Market Share by Type In 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Checkpoint Inhibitors Sales in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Checkpoint Inhibitors Revenue in 2019
Figure 19. Immune Checkpoint Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. North America Immune Checkpoint Inhibitors Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 21. North America Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026) (MT)
Figure 22. Asia-Pacific Immune Checkpoint Inhibitors Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 23. Asia-Pacific Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026) (MT)
Figure 24. Europe Immune Checkpoint Inhibitors Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 25. Europe Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026) (MT)
Figure 26. Latin America Immune Checkpoint Inhibitors Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 27. Latin America Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026) (MT)
Figure 28. Middle East and Africa Immune Checkpoint Inhibitors Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 29. Middle East and Africa Immune Checkpoint Inhibitors Sales YoY Growth (2015-2026) (MT)
Figure 30. Lung Cancer Examples
Figure 31. Colorectal Cancer Examples
Figure 32. Breast Cancer Examples
Figure 33. Prostate Cancer Examples
Figure 34. Melanoma Examples
Figure 35. Blood Cancer Examples
Figure 36. Other Examples
Figure 37. U.S. Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 38. U.S. Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 39. Canada Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 40. Canada Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 41. Germany Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 42. Germany Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 43. France Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 44. France Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 45. U.K. Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 46. U.K. Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 47. Italy Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 48. Italy Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 49. Russia Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 50. Russia Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 51. China Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 52. China Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 53. Japan Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 54. Japan Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 55. South Korea Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 56. South Korea Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 57. India Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 58. India Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 59. Australia Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 60. Australia Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 61. Taiwan Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 62. Taiwan Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 63. Indonesia Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 64. Indonesia Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 65. Thailand Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 66. Thailand Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 67. Malaysia Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 68. Malaysia Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 69. Philippines Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 70. Philippines Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 71. Vietnam Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 72. Vietnam Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 73. Mexico Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 74. Mexico Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 75. Brazil Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 76. Brazil Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 77. Argentina Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 78. Argentina Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 79. Turkey Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 80. Turkey Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 81. Saudi Arabia Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 82. Saudi Arabia Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 83. U.A.E Immune Checkpoint Inhibitors Sales (MT) (2015-2026)
Figure 84. U.A.E Immune Checkpoint Inhibitors Revenue (US$ Million) (2015-2026)
Figure 85. Bristol Myer Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Roche / Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Incyte Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. NewLink Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. ArGEN-X Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Seattle Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. MacroGenics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Celldex Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. CureTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Immutep Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Innate Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Sorrento Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. GITR, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Key Raw Materials Price
Figure 103. Immune Checkpoint Inhibitors Manufacturing Cost Structure
Figure 104. Immune Checkpoint Inhibitors Industrial Chain Analysis
Figure 105. Porter's Five Forces Analysis
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
Keyplayers in Global Immune Checkpoint Inhibitors Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
Bristol Myer SquibbAstraZeneca
Merck & Co.
Roche / Genentech
Incyte Corporation
NewLink Genetics
ArGEN-X
Seattle Genetics
Pfizer
MacroGenics
Celldex Therapeutics
CureTech
Immutep
Innate Pharma
Sorrento Therapeutics
GlaxoSmithKline
GITR, Inc